Pediatric Dermatology

Study shows alarming upward trend in teen use of indoor tanning facilities

Pimecrolimus offers effective, safe option for hand dermatitis

Several hormones are involved in the abnormal follicular exfoliation that causes acne.

Not soothing

FIGHT AGE SPOTS

NEW DOSAGE OK'D

'Simple, doable,' nbut each state must approve

Researchers looking to manipulate skin physiology to make blood vessels more vulnerable to lasers

1-Write Prescription System helps eliminateunnecessary calls from patients, pharmacists

Israelis decode gene

Face 'cradle' helps speed recovery after surgery

Educating patients makes a difference

Dermatitis' can be catch-all label for unexplainable skin conditions

Healing waters: Natural hot springs help AD sufferers

Combination of several agents may be future of AD treatment

Contact dermatitis:New science, new solutions

Irritant contact dermatis poses a diagnostic puzzle.

Pediatric AD: More cases, more choices

Searching for a cause and solution to seborrheic dermatitis

French drug maker Aventis agreed April 25 to accept a sweetened takeover offer from national rival Sanofi-Synth?labo.

New terms to begin in 2005 and 2006

May inhibit secretion of vascular endothelial growth factor, which stimulates tumor progression

Boca Raton, Fla. - Contact dermatitis from topical medications is the most common type of adverse drug reaction, and allergic contact dermatitis is the most common and most important form of contact dermatitis induced by topical drugs, according to James S. Taylor, M.D., head of the industrial dermatology section of the department of dermatology at the Cleveland Clinic Foundation in Cleveland. "Patients with medicament contact dermatitis usually have a good prognosis, but with a propensity for relapse," he said.

Washington - In the treatment of moderate-to-severe atopic dermatitis, pimecrolimus (Elidel) cream 1 percent is less likely than tacrolimus (Protopic) ointment 0.1 percent to be systemically absorbed, said Zoe Draelos, M.D., lead investigator of a blind treatment trial that compared systemic exposure levels of the two topical drugs.

Washington - Pimecrolimus cream 1 percent showed better local tolerability than tacrolimus ointment 0.03 percent in pediatric patients with moderate atopic dermatitis, and the patients or their primary caregivers rated most of the formulation attributes of the pimecrolimus cream as being significantly better than those of the tacrolimus ointment, according to a recent Phase IV study presented at the American Academy of Dermatology annual meeting.